Seer, Inc. Class A Common Stock
$1.93
$0.03 (+1.32%)
$1.89Day Range$1.94
Key Statistics
Market Cap
$105.21M
Shares Outstanding
55.4M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Dec 4, 2020
Round Lot
100
Locale
US
Trading Data
Day Open
$1.90
Day High
$1.94
Day Low
$1.89
Volume
117.0K
VWAP
$1.91
Prev Close
$1.90
Transactions
--
Acc. Volume
--
About Seer, Inc. Class A Common Stock
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
LABORATORY ANALYTICAL INSTRUMENTSSIC 3826124 employees3800 BRIDGE PARKWAY, SUITE 102, REDWOOD CITY, CA, 94065650-453-0000IPO Dec 4, 2020US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001726445
- Composite FIGI
- BBG00HPLTRR8
- Share Class FIGI
- BBG00HPLTRS7
- Ticker Root
- SEER
- SIC Code
- 3826
About Seer, Inc. Class A Common Stock (SEER) Stock
Seer, Inc. Class A Common Stock (SEER) closed the 2026-09-16 session at $1.93, up 1.32% versus the previous close (+0.03). The stock opened at $1.90 and traded between $1.89 and $1.94 during that session. Session trading volume was 117K shares. The volume-weighted average price (VWAP) is $1.91.
Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.
Seer, Inc. Class A Common Stock has a market capitalization of $105.2 million. The company operates in the LABORATORY ANALYTICAL INSTRUMENTS industry classification. SEER is listed on the XNAS exchange. The company employs approximately 124 people. Seer, Inc. Class A Common Stock is headquartered in REDWOOD CITY, CA. The recorded listing date is 2020-12-04.
On this page you can find market SEER stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the LABORATORY ANALYTICAL INSTRUMENTS sector.